Welcome to LookChem.com Sign In|Join Free
  • or
2-Amino-6-methyl-4-pyrimidinol, also known as an aminopyrimidine compound, is a white powder with its amino group at position 2 and hydroxy and methyl substituents at positions 4 and 6, respectively. It is a versatile chemical compound that has potential applications in various industries due to its unique structure and properties.

3977-29-5

Post Buying Request

3977-29-5 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

3977-29-5 Usage

Uses

Used in Pharmaceutical Industry:
2-Amino-6-methyl-4-pyrimidinol is used as an intermediate in the synthesis of various pharmaceutical compounds for [application reason]. Its unique structure allows for the development of new drugs with potential therapeutic benefits.
Used in Chemical Synthesis:
2-Amino-6-methyl-4-pyrimidinol is used as a building block in the chemical synthesis of various organic compounds for [application reason]. Its reactivity and functional groups make it a valuable component in the creation of new molecules with specific properties.
Used in Research and Development:
2-Amino-6-methyl-4-pyrimidinol is used as a research compound for [application reason] in academic and industrial laboratories. Its unique structure and properties make it an interesting subject for studying various chemical reactions and exploring its potential applications in different fields.
Used in Material Science:
2-Amino-6-methyl-4-pyrimidinol is used as a component in the development of new materials for [application reason], such as in the creation of advanced polymers or coatings with specific properties. Its unique structure and functional groups can contribute to the development of innovative materials with improved performance characteristics.

Check Digit Verification of cas no

The CAS Registry Mumber 3977-29-5 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 3,9,7 and 7 respectively; the second part has 2 digits, 2 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 3977-29:
(6*3)+(5*9)+(4*7)+(3*7)+(2*2)+(1*9)=125
125 % 10 = 5
So 3977-29-5 is a valid CAS Registry Number.
InChI:InChI=1/C5H7N3O/c1-3-2-4(9)8-5(6)7-3/h2H,1H3,(H3,6,7,8,9)

3977-29-5 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • Alfa Aesar

  • (B24604)  2-Amino-4-hydroxy-6-methylpyrimidine, 98%   

  • 3977-29-5

  • 50g

  • 331.0CNY

  • Detail
  • Alfa Aesar

  • (B24604)  2-Amino-4-hydroxy-6-methylpyrimidine, 98%   

  • 3977-29-5

  • 250g

  • 1334.0CNY

  • Detail
  • Aldrich

  • (A58003)  2-Amino-4-hydroxy-6-methylpyrimidine  98%

  • 3977-29-5

  • A58003-25G

  • 304.20CNY

  • Detail
  • Aldrich

  • (A58003)  2-Amino-4-hydroxy-6-methylpyrimidine  98%

  • 3977-29-5

  • A58003-100G

  • 866.97CNY

  • Detail

3977-29-5SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 11, 2017

Revision Date: Aug 11, 2017

1.Identification

1.1 GHS Product identifier

Product name 2-Amino-4-hydroxy-6-methylpyrimidine

1.2 Other means of identification

Product number -
Other names 2-amino-6-methyl-1H-pyrimidin-4-one

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:3977-29-5 SDS

3977-29-5Synthetic route

2-amino-6-methylpyrimidin-4-ol

2-amino-6-methylpyrimidin-4-ol

3-methoxy-but-2-enoic acid ethyl ester
3510-99-4

3-methoxy-but-2-enoic acid ethyl ester

guanidine hydrochloride
50-01-1

guanidine hydrochloride

2-amino-6-methylpyrimidin-4-ol
3977-29-5

2-amino-6-methylpyrimidin-4-ol

Conditions
ConditionsYield
In methanol at 100℃; for 3h; Solvent;62.1%
guanidine nitrate
113-00-8

guanidine nitrate

2-amino-6-methylpyrimidin-4-ol
3977-29-5

2-amino-6-methylpyrimidin-4-ol

Conditions
ConditionsYield
In ethanol; acetone at 20℃; for 10h;52%
diguanidine carbonate
593-85-1

diguanidine carbonate

ethyl acetoacetate
141-97-9

ethyl acetoacetate

2-amino-6-methylpyrimidin-4-ol
3977-29-5

2-amino-6-methylpyrimidin-4-ol

Conditions
ConditionsYield
In ethanol Heating;
guanidine hydrochloride
50-01-1

guanidine hydrochloride

acetoacetic acid methyl ester
105-45-3

acetoacetic acid methyl ester

2-amino-6-methylpyrimidin-4-ol
3977-29-5

2-amino-6-methylpyrimidin-4-ol

Conditions
ConditionsYield
With potassium tert-butylate In methanol at 23 - 60℃;
guanidine nitrate
506-93-4

guanidine nitrate

ethyl acetoacetate
141-97-9

ethyl acetoacetate

2-amino-6-methylpyrimidin-4-ol
3977-29-5

2-amino-6-methylpyrimidin-4-ol

Conditions
ConditionsYield
With potassium n-butoxide In butan-1-ol
2-amino-6-methylpyrimidin-4-ol
3977-29-5

2-amino-6-methylpyrimidin-4-ol

2-amino-6-methyl-4-chloropyrimidine
5600-21-5

2-amino-6-methyl-4-chloropyrimidine

Conditions
ConditionsYield
With trichlorophosphate for 2h; Reflux;98%
With trichlorophosphate Heating;
With tetraethylammonium chloride; N,N-dimethyl-aniline; trichlorophosphate In acetonitrile at 110℃; for 0.333333h;
2-amino-6-methylpyrimidin-4-ol
3977-29-5

2-amino-6-methylpyrimidin-4-ol

1,1'-carbonyldiimidazole
530-62-1

1,1'-carbonyldiimidazole

N-(4-methyl-6-oxo-1,6-dihydropyrimidin-2-yl)-1H-imidazole-1-carboxamide
561316-60-7

N-(4-methyl-6-oxo-1,6-dihydropyrimidin-2-yl)-1H-imidazole-1-carboxamide

Conditions
ConditionsYield
In dimethyl sulfoxide at 80℃; for 1h;98%
2-amino-6-methylpyrimidin-4-ol
3977-29-5

2-amino-6-methylpyrimidin-4-ol

Hexamethylene diisocyanate
822-06-0

Hexamethylene diisocyanate

2-(6-isocyanato-hexylaminocarbonylamino)-6-methyl-4(1H)-pyrimidinone
320393-85-9

2-(6-isocyanato-hexylaminocarbonylamino)-6-methyl-4(1H)-pyrimidinone

Conditions
ConditionsYield
at 100℃; for 16h;98%
at 100℃; for 12h; Inert atmosphere;90%
1-isocyanatooctane
3158-26-7

1-isocyanatooctane

2-amino-6-methylpyrimidin-4-ol
3977-29-5

2-amino-6-methylpyrimidin-4-ol

1-(6-methyl-4-oxo-1,4-dihydropyrimidin-2-yl)-3-octylurea

1-(6-methyl-4-oxo-1,4-dihydropyrimidin-2-yl)-3-octylurea

Conditions
ConditionsYield
In tetrahydrofuran for 48h; Heating;97%
97%
2-amino-6-methylpyrimidin-4-ol
3977-29-5

2-amino-6-methylpyrimidin-4-ol

Hexamethylene diisocyanate
822-06-0

Hexamethylene diisocyanate

2-(6-isocyanatohexylaminocarbonylamino)-6-methyl-4-pyrimidinone
320393-85-9

2-(6-isocyanatohexylaminocarbonylamino)-6-methyl-4-pyrimidinone

Conditions
ConditionsYield
With pyridine at 100℃; Inert atmosphere;95%
at 95℃; for 18h; Inert atmosphere;94%
With pyridine In pentane at 100℃; Inert atmosphere;90%
2-amino-6-methylpyrimidin-4-ol
3977-29-5

2-amino-6-methylpyrimidin-4-ol

5-(4-Nitro-phenyl)-furan-2-carbonyl isothiocyanate
140160-21-0

5-(4-Nitro-phenyl)-furan-2-carbonyl isothiocyanate

1-(4-hydroxy-6-methyl-pyrimidin-2-yl)-3-[5-(4-nitro-phenyl)-furan-2-carbonyl]-thiourea
847981-73-1

1-(4-hydroxy-6-methyl-pyrimidin-2-yl)-3-[5-(4-nitro-phenyl)-furan-2-carbonyl]-thiourea

Conditions
ConditionsYield
With PEG-400 In acetonitrile ultrasonic irradiation;86%
α-bromoacetophenone
70-11-1

α-bromoacetophenone

2-amino-6-methylpyrimidin-4-ol
3977-29-5

2-amino-6-methylpyrimidin-4-ol

5-hydroxy-7-methyl-2-phenylimidazo[1,2-a]pyrimidine
95980-02-2

5-hydroxy-7-methyl-2-phenylimidazo[1,2-a]pyrimidine

Conditions
ConditionsYield
In N,N-dimethyl-formamide for 4h; Reflux; Inert atmosphere;85%
In N,N-dimethyl-formamide for 3h; Heating;80%
2-amino-6-methylpyrimidin-4-ol
3977-29-5

2-amino-6-methylpyrimidin-4-ol

benzoic acid
65-85-0

benzoic acid

2-benzamido-6-methylisocytosine
54286-79-2

2-benzamido-6-methylisocytosine

Conditions
ConditionsYield
With dmap; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In chloroform85%
2-amino-6-methylpyrimidin-4-ol
3977-29-5

2-amino-6-methylpyrimidin-4-ol

2-amino-4-hydroxy-6-methyl-5-nitropyrimidine
4214-85-1

2-amino-4-hydroxy-6-methyl-5-nitropyrimidine

Conditions
ConditionsYield
With sulfuric acid; nitric acid for 0.75h; Ambient temperature;83%
2-amino-6-methylpyrimidin-4-ol
3977-29-5

2-amino-6-methylpyrimidin-4-ol

4-(1,1-dimethylethyl)benzoic acid
98-73-7

4-(1,1-dimethylethyl)benzoic acid

2-(4'-tert-butyl)benzamido-6-methylisocytosine
1260495-73-5

2-(4'-tert-butyl)benzamido-6-methylisocytosine

Conditions
ConditionsYield
With dmap; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In chloroform for 16h; Inert atmosphere; Reflux;83%
Hexyl isocyanate
2525-62-4

Hexyl isocyanate

2-amino-6-methylpyrimidin-4-ol
3977-29-5

2-amino-6-methylpyrimidin-4-ol

N-hexyl-N'-(6-methyl-4-oxo-1,4-dihydropyrimidin-2-yl)urea

N-hexyl-N'-(6-methyl-4-oxo-1,4-dihydropyrimidin-2-yl)urea

Conditions
ConditionsYield
With pyridine for 16h; Heating;82%
6-Hydroxy-2-naphthoic acid
16712-64-4

6-Hydroxy-2-naphthoic acid

2-amino-6-methylpyrimidin-4-ol
3977-29-5

2-amino-6-methylpyrimidin-4-ol

C11H8O3*2C5H7N3O

C11H8O3*2C5H7N3O

Conditions
ConditionsYield
In ethanol; water for 240h;82%
4-nitrobenzenediazonium chloride
100-05-0

4-nitrobenzenediazonium chloride

2-amino-6-methylpyrimidin-4-ol
3977-29-5

2-amino-6-methylpyrimidin-4-ol

2-Amino-6-methyl-5-(4-nitro-phenylazo)-pyrimidin-4-ol

2-Amino-6-methyl-5-(4-nitro-phenylazo)-pyrimidin-4-ol

Conditions
ConditionsYield
81%
3-nitrophenyldiazonium chloride
2028-76-4

3-nitrophenyldiazonium chloride

2-amino-6-methylpyrimidin-4-ol
3977-29-5

2-amino-6-methylpyrimidin-4-ol

2-Amino-6-methyl-5-(3-nitro-phenylazo)-pyrimidin-4-ol

2-Amino-6-methyl-5-(3-nitro-phenylazo)-pyrimidin-4-ol

Conditions
ConditionsYield
81%
p-chlorobenzenediazonium chloride
2028-74-2

p-chlorobenzenediazonium chloride

2-amino-6-methylpyrimidin-4-ol
3977-29-5

2-amino-6-methylpyrimidin-4-ol

2-Amino-5-(4-chloro-phenylazo)-6-methyl-pyrimidin-4-ol

2-Amino-5-(4-chloro-phenylazo)-6-methyl-pyrimidin-4-ol

Conditions
ConditionsYield
80%
2-nitrobenzenediazonium chloride
119-66-4

2-nitrobenzenediazonium chloride

2-amino-6-methylpyrimidin-4-ol
3977-29-5

2-amino-6-methylpyrimidin-4-ol

2-Amino-6-methyl-5-(2-nitro-phenylazo)-pyrimidin-4-ol

2-Amino-6-methyl-5-(2-nitro-phenylazo)-pyrimidin-4-ol

Conditions
ConditionsYield
80%
2-chlorobenzenediazonium chloride
89-90-7

2-chlorobenzenediazonium chloride

2-amino-6-methylpyrimidin-4-ol
3977-29-5

2-amino-6-methylpyrimidin-4-ol

2-Amino-5-(2-chloro-phenylazo)-6-methyl-pyrimidin-4-ol

2-Amino-5-(2-chloro-phenylazo)-6-methyl-pyrimidin-4-ol

Conditions
ConditionsYield
78%
2-amino-6-methylpyrimidin-4-ol
3977-29-5

2-amino-6-methylpyrimidin-4-ol

Glycine ethyl ester isocyanate
2949-22-6

Glycine ethyl ester isocyanate

[3-(6-methyl-4-oxo-1,4-dihydropyrimidin-2-yl)ureido]acetic acid ethyl ester
583040-82-8

[3-(6-methyl-4-oxo-1,4-dihydropyrimidin-2-yl)ureido]acetic acid ethyl ester

Conditions
ConditionsYield
With pyridine for 3h; Heating;78%
2-amino-6-methylpyrimidin-4-ol
3977-29-5

2-amino-6-methylpyrimidin-4-ol

5-(2-chlorophenyl)-2-furoylisothiocyanate
304437-60-3

5-(2-chlorophenyl)-2-furoylisothiocyanate

1-[5-(2-chloro-phenyl)-furan-2-carbonyl]-3-(4-hydroxy-6-methyl-pyrimidin-2-yl)-thiourea

1-[5-(2-chloro-phenyl)-furan-2-carbonyl]-3-(4-hydroxy-6-methyl-pyrimidin-2-yl)-thiourea

Conditions
ConditionsYield
With PEG-400 In acetonitrile ultrasonic irradiation;77%
2-bromo benzene diazonium chloride
34835-57-9

2-bromo benzene diazonium chloride

2-amino-6-methylpyrimidin-4-ol
3977-29-5

2-amino-6-methylpyrimidin-4-ol

2-Amino-5-(2-bromo-phenylazo)-6-methyl-pyrimidin-4-ol

2-Amino-5-(2-bromo-phenylazo)-6-methyl-pyrimidin-4-ol

Conditions
ConditionsYield
76%
2-amino-6-methylpyrimidin-4-ol
3977-29-5

2-amino-6-methylpyrimidin-4-ol

2,3'-dibromoacetophenone
18523-22-3

2,3'-dibromoacetophenone

2-(3-bromophenyl)-7-methylimidazo[1,2-a]pyrimidin-5-ol

2-(3-bromophenyl)-7-methylimidazo[1,2-a]pyrimidin-5-ol

Conditions
ConditionsYield
In N,N-dimethyl-formamide for 4h; Reflux; Inert atmosphere;76%
benzene diazonium chloride
100-34-5

benzene diazonium chloride

2-amino-6-methylpyrimidin-4-ol
3977-29-5

2-amino-6-methylpyrimidin-4-ol

2-amino-4-hydroxy-6-methyl-5-phenylazopyrimidine

2-amino-4-hydroxy-6-methyl-5-phenylazopyrimidine

Conditions
ConditionsYield
75%
(4-bromophenyl)diazonium chloride
2028-85-5

(4-bromophenyl)diazonium chloride

2-amino-6-methylpyrimidin-4-ol
3977-29-5

2-amino-6-methylpyrimidin-4-ol

2-Amino-5-(4-bromo-phenylazo)-6-methyl-pyrimidin-4-ol

2-Amino-5-(4-bromo-phenylazo)-6-methyl-pyrimidin-4-ol

Conditions
ConditionsYield
74%
2,3,5,6-tetrafluoroterephthalic acid
652-36-8

2,3,5,6-tetrafluoroterephthalic acid

water
7732-18-5

water

2-amino-6-methylpyrimidin-4-ol
3977-29-5

2-amino-6-methylpyrimidin-4-ol

C5H8N3O(1+)*0.5C8F4O4(2-)*0.5C8H2F4O4*H2O

C5H8N3O(1+)*0.5C8F4O4(2-)*0.5C8H2F4O4*H2O

Conditions
ConditionsYield
In 1,4-dioxane74%
3-methoxy-benzenediazonium; chloride
19183-05-2

3-methoxy-benzenediazonium; chloride

2-amino-6-methylpyrimidin-4-ol
3977-29-5

2-amino-6-methylpyrimidin-4-ol

2-Amino-5-(3-methoxy-phenylazo)-6-methyl-pyrimidin-4-ol

2-Amino-5-(3-methoxy-phenylazo)-6-methyl-pyrimidin-4-ol

Conditions
ConditionsYield
72%
N-4-N,N-dimethylaminophenylmethylene-2-methyl-5-4H-oxazoline
1787-23-1

N-4-N,N-dimethylaminophenylmethylene-2-methyl-5-4H-oxazoline

2-amino-6-methylpyrimidin-4-ol
3977-29-5

2-amino-6-methylpyrimidin-4-ol

1-(4-chloro-6-methylpyrimidin-2-yl)-4-(4-(dimethylamino)benzylidene)-2-methyl-1H-imidazol-5(4H)-one
1575728-38-9

1-(4-chloro-6-methylpyrimidin-2-yl)-4-(4-(dimethylamino)benzylidene)-2-methyl-1H-imidazol-5(4H)-one

Conditions
ConditionsYield
With potassium acetate; acetic acid Heating;71%
para-methoxyphenyldiazonium chloride
4346-59-2

para-methoxyphenyldiazonium chloride

2-amino-6-methylpyrimidin-4-ol
3977-29-5

2-amino-6-methylpyrimidin-4-ol

2-Amino-5-(4-methoxy-phenylazo)-6-methyl-pyrimidin-4-ol

2-Amino-5-(4-methoxy-phenylazo)-6-methyl-pyrimidin-4-ol

Conditions
ConditionsYield
70%
iodotrifluoromethane
2314-97-8

iodotrifluoromethane

2-amino-6-methylpyrimidin-4-ol
3977-29-5

2-amino-6-methylpyrimidin-4-ol

2-amino-5-trifluoromethyl-4-hydroxy-6-methylpyrimidine
1063697-18-6

2-amino-5-trifluoromethyl-4-hydroxy-6-methylpyrimidine

Conditions
ConditionsYield
With dihydrogen peroxide; iron(II) sulfate In water; dimethyl sulfoxide70%
2-methyl-4-(4-chlorobenzylidene)-4H-oxazol-5-one
93634-55-0, 3237-71-6

2-methyl-4-(4-chlorobenzylidene)-4H-oxazol-5-one

2-amino-6-methylpyrimidin-4-ol
3977-29-5

2-amino-6-methylpyrimidin-4-ol

4-(4-chlorobenzylidene)-1-(4-hydroxy-6-methylpyrimidin-2-yl)-2-phenyl-1H-imidazol-5(4H)-one
1575727-87-5

4-(4-chlorobenzylidene)-1-(4-hydroxy-6-methylpyrimidin-2-yl)-2-phenyl-1H-imidazol-5(4H)-one

Conditions
ConditionsYield
With potassium acetate; acetic acid Heating;69%

3977-29-5Relevant academic research and scientific papers

Synthesis and Plant Growth Stimulating Action of 2-Amino-6-methylpyrimidine-4(3H)-thione Derivatives

Hambardzumyan, E. N.,Shahbazyan, L. V.,Vorskanyan, A. S.,Yengoyan, A. P.

, p. 208 - 216 (2020)

Abstract: A series of new pyrimidine derivatives, including those containing an azole or azine heterocycle linked through a sulfur atom or a thiomethylene group, was synthesized based on 2-amino-6-methylpyrimidine-4(3H)-thione. The synthesized compounds exhibited a pronounced stimulating effect on plants growth in the range of 43–96% compared to heteroauxin.

Synthesis, crystal structure, and ADME prediction studies of novel imidazopyrimidines as antibacterial and cytotoxic agents

Abdel-Mohsen, Heba T.,Abood, Amira,El Diwani, Hoda I.,Flanagan, Keith J.,Meindl, Alina,Senge, Mathias O.

, (2020)

In the present study, a novel series of polyfunctionalized imidazopyrimidines 6a–u and 9a–d were efficiently constructed by a domino reaction between 2-imino-6-substituted-2,3-dihydropyrimidin-4(1H)-ones 4a–d or 8a–c and 2-bromoacetophenones 5a–i under mild basic conditions. The synthesized series were screened for their antibacterial activity against Staphylococcus aureus and Bacillus subtilis as Gram-positive (+) bacteria, as well as against Gram-negative (?) bacteria Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa, and Salmonella typhi. Most of the synthesized derivatives of imidazopyrimidines 6 and 9 showed remarkable selectivity against Gram(?) bacteria over the Gram(+) ones. Compounds 6c, 6f, and 6g displayed potent and broad-spectrum antibacterial activity against all tested strains. Compounds 6f and 6g displayed promising inhibitory activity on GryB ATPase from E. coli with IC50 = 1.14 and 0.73 μM, respectively. Simultaneously, some of the synthesized imidazopyrimidines were screened for their antiproliferative activity against 60 cancer cell lines at a concentration of 10 μM. Compound 9d showed potent activity against most of the tested cell lines, with a mean growth inhibition of 37%. The ADME (absorption, distribution, metabolism, and excretion) prediction study demonstrated that the synthesized hits have, in addition to their promising chemotherapeutic activity, acceptable pharmacokinetic properties, and a drug-likeness nature to be further developed.

Regioselective synthesis of 6-substituted-2-amino-5-bromo-4(3H)- pyrimidinones and evaluation of their antiviral activity

Singh, Kamaljit,Singh, Kawaljit,Balzarini, Jan

, p. 428 - 433 (2013)

A series of 2-amino-5-bromo-4(3 H)-pyrimidinone derivatives bearing different substituents at the C-6 position were synthesized using a highly regioselective lithiation-substitution protocol, and the effect of structural variation at the C-6 position on their antiviral activity in cell culture was evaluated. Although some of the derivatives were found to be active against various virus strains, they were effective only close to their toxicity threshold.

2-Pivalamido-3H-pyrimidin-4-one derivatives: Convenient pivalamide hydrolysis using Fe(NO3)3 in MeOH

Bavetsias,Henderson,McDonald

, p. 5643 - 5644 (2004)

A simple methodology for pivalamide (trimethylacetamide, pivaloylamino) hydrolysis has been discovered using Fe(NO3)3 in MeOH at room temperature. The pivalamido group of 2-pivalamido-3H-pyrimidin-4-ones or fused 2-pivalamido-3H-pyrimidin-4-ones such as 2-pivalamido-3H-quinazolin-4-ones and 2-pivalamido-3H-pteridines have been hydrolysed under these conditions to afford the corresponding amine.

Theoretical investigation on the reactivity and photophysical properties of cobalt(II) and manganese(II) complexes constructed using Schiff base ligands based on ALIE and TDDFT calculations

Prasad, Kollur Shiva,Pillai, Renjith Raveendran,Armakovi?, Stevan,Armakovi?, Sanja J.

, p. 141 - 148 (2017)

Herein, we describe the synthesis of two novel Schiff base ligands, 2-[(3-bromo-5-hydroxybenzylidene)-amino]-6-methylpyrimidin-4-ol (1) and 3-bromo-5-[(5-methylthiazol-2-ylimino)methyl]phenol (2), and their Co(II) and Mn(II) complexes (4–6). The molecular

Ultrasound-assisted rapid synthesis of 2-aminopyrimidine and barbituric acid derivatives

Bayramo?lu, Duygu,Kurtay, Gülbin,Güllü, Mustafa

, p. 649 - 658 (2020/02/11)

Novel, inexpensive, and relatively expeditious procedure to achieve the synthesis of different 2-aminopyrimidine and barbituric acid derivatives is presented here, starting from readily available compounds such as guanidine hydrochloride, urea, 1,3-dialkylurea, or thiourea. Under ultrasonic irradiation, base-driven (Na2CO3, NaOH, or NaOC2H5) heterocyclization reactions of the aforementioned substrates with diethyl malonate, diethyl-2-alkyl malonate, pentane-2,4-dione, or ethyl-3-oxobutanoate yielded corresponding products. Significant advantages of this sonochemical synthetic protocol with regard to the conventional thermal methods include easy reaction setup and work-up steps, reasonably mild conditions, shorter reaction times (~30 min) and comparably high product yields. The characterization of the synthesized compounds was based on melting points, FT-IR, GC-MS, 1H-NMR techniques, and the obtained data were also checked from the previously published studies.

Synthesis and Investigation of Phthalazinones as Antitubercular Agents

Santoso, Kristiana T.,Cheung, Chen-Yi,Hards, Kiel,Cook, Gregory M.,Stocker, Bridget L.,Timmer, Mattie S. M.

supporting information, p. 1278 - 1285 (2019/02/24)

A series of 2- and 7-substituted phthalazinones was synthesised and their potential as anti-tubercular drugs assessed via Mycobacterium tuberculosis (mc26230) growth inhibition assays. All phthalazinones tested showed growth inhibitory activity (MIC 100 μm), and those compounds containing lipophilic and electron-withdrawing groups generally exhibited better anti-tubercular activity. Several lead compounds were identified, including 7-((2-amino-6-(4-fluorophenyl)pyrimidin-4-yl)amino)-2-heptylphthalazin-1(2H)-one (MIC=1.6 μm), 4-tertbutylphthalazin-2(1H)-one (MIC=3 μm), and 7-nitro-phthalazin-1(2H)-one (MIC=3 μm). Mode of action studies indicated that selected pyrimidinyl-phthalazinones may interfere with NADH oxidation, however, the mode of action of the lead compound is independent of this enzyme. MIC=minimum inhibitory concentration.

Structure-based design, synthesis and evaluation of 2,4-diaminopyrimidine derivatives as novel caspase-1 inhibitors

Patel, Shivani,Modi, Palmi,Ranjan, Vishal,Chhabria, Mahesh

, p. 258 - 268 (2018/04/05)

Interleukin-1β converting enzyme contributes in various inflammatory and autoimmune diseases by maturing pro-inflammatory cytokines IL-1β, IL-18 and IL-33. Therefore, inhibition caspase-1 may provide a potential therapeutic strategy for the treatment of chronic inflammatory diseases. Here we have reported structure-based design, synthesis and biological evaluation of 2,4-diaminopyrimidine derivatives (6a-6w) as potential caspase-1 inhibitors. Six compounds 6m, 6n, 6o, 6p, 6q and 6r showed significant enzymatic inhibition with IC5 0 ranging from 0.022 to 0.078 μM. These compounds also displayed excellent cellular potency at sub-micromolar concentration. Moreover, molecular docking studies provided the useful binding insights specific for caspase-1 inhibition. All these results indicated that compounds 6m, 6n and 6o could be potential leads for the development of newer caspase-1 inhibitors as anti-inflammatory agents.

Synthesizing method of 2-amino-4-hydroxyl-6-methylpyrimidine

-

Paragraph 0025; 0026; 0027; 0028; 0029; 0034-0039, (2017/10/10)

The invention relates to a synthesizing method of 2-amino-4-hydroxyl-6-methylpyrimidine. The synthesizing method comprises the following steps of (a) synthesizing of 2-methoxyl-2-ethyl butyrate: mixing ethyl acetate and a catalyst, after heating and refluxing, performing self-condensation reaction of the ethyl acetate, so as to obtain the 2-methoxyl-2-ethyl butyrate; (b) synthesizing of 2-amino-4-hydroxyl-6-methylpyrimidine; dissolving the 2-methoxyl-2-ethyl butyrate into methyl alcohol, dissolving, mixing with guanidine hydrochloride, after heating and refluxing, evaporating the residual solvent, adding deionized water until completely dissolving, using diluted hydrochloric acid to adjust the pH (potential of hydrogen) value, separating solid and filtering, spraying the solid by deionized water, obtaining the 2-amino-4-hydroxyl-6-methylpyrimidine, and drying. The synthesizing method has the advantages that the toxicity of the raw material is low, the cost is low, and the green and environment-friendly effects are realized; the traditional synthesizing method using volatile acetone with stronger toxicity or phenylboronic acid with hypertoxicity is improved, the injury to production personnels and environments is decreased, and the difficulty in production is reduced.

9-Benzoyl 9-deazaguanines as potent xanthine oxidase inhibitors

Rodrigues, Marili V.N.,Barbosa, Alexandre F.,Da Silva, Júlia F.,Dos Santos, Deborah A.,Vanzolini, Kenia L.,De Moraes, Marcela C.,Corrêa, Arlene G.,Cass, Quezia B.

, p. 226 - 231 (2015/12/31)

A novel potent xanthine oxidase inhibitor, 3-nitrobenzoyl 9-deazaguanine (LSPN451), was selected from a series of 10 synthetic derivatives. The enzymatic assays were carried out using an on-flow bidimensional liquid chromatography (2D LC) system, which allowed the screening the measurement of the kinetic inhibition constant and the characterization of the inhibition mode. This compound showed a non-competitive inhibition mechanism with more affinity for the enzyme-substrate complex than for the free enzyme, and inhibition constant of 55.1 ± 9.80 nM, about thirty times more potent than allopurinol. Further details of synthesis and enzymatic studies are presented herein.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 3977-29-5